Genetic Signatures Limited
ASX:GSS.AX
0.675 (AUD) • At close October 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 9.766 | 16.939 | 35.421 | 28.284 | 11.263 | 7.024 | 4.994 | 4.062 | 3.266 | 1.043 | 1.293 | 0.257 |
| Cost of Revenue
| 5.458 | 29.678 | 28.209 | 24.014 | 13.628 | 2.861 | 1.983 | 1.724 | 1.016 | 0.395 | 0.607 | 0.398 |
| Gross Profit
| 4.308 | -12.739 | 7.212 | 4.27 | -2.365 | 4.163 | 3.011 | 2.338 | 2.25 | 0.648 | 0.686 | -0.141 |
| Gross Profit Ratio
| 0.441 | -0.752 | 0.204 | 0.151 | -0.21 | 0.593 | 0.603 | 0.576 | 0.689 | 0.621 | 0.531 | -0.549 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 15.139 | 1.49 | 0.564 | 0.399 | 0.443 | 0.432 | 0.494 | 0.385 | 0.461 | 2.373 | 0.377 | 0.201 |
| Selling & Marketing Expenses
| 0 | 1.284 | 1.524 | 1.318 | 0.566 | 5.28 | 4.313 | 3.525 | 3.747 | 0 | 1.122 | 1.435 |
| SG&A
| 15.139 | 6.304 | 4.255 | 2.842 | 2.465 | 5.712 | 4.807 | 3.911 | 4.208 | 2.373 | 1.498 | 1.636 |
| Other Expenses
| 11.502 | 0.152 | 0.01 | 0.129 | 2.639 | 2.098 | 2.154 | 1.758 | 1.533 | 0.407 | 0 | 0 |
| Operating Expenses
| 26.641 | 6.152 | 4.245 | 2.713 | 2.465 | 7.823 | 6.494 | 5.26 | 5.367 | 3.755 | 2.141 | 2.109 |
| Operating Income
| -22.333 | -18.891 | 2.967 | 1.557 | -4.83 | -3.599 | -3.398 | -2.783 | -2.998 | -3.107 | -1.235 | -2.261 |
| Operating Income Ratio
| -2.287 | -1.115 | 0.084 | 0.055 | -0.429 | -0.512 | -0.68 | -0.685 | -0.918 | -2.978 | -0.955 | -8.799 |
| Total Other Income Expenses Net
| 4.471 | 0.418 | 0.096 | 0.199 | 0.19 | 0.107 | 0.144 | 0.112 | -0.029 | 0.407 | -0.494 | -0.282 |
| Income Before Tax
| -17.862 | -18.473 | 3.063 | 1.756 | -4.64 | -3.492 | -3.254 | -2.671 | -3.027 | -2.659 | -1.728 | -2.543 |
| Income Before Tax Ratio
| -1.829 | -1.091 | 0.086 | 0.062 | -0.412 | -0.497 | -0.652 | -0.658 | -0.927 | -2.549 | -1.337 | -9.897 |
| Income Tax Expense
| -3.992 | -4.421 | 1.388 | 1.188 | -2.554 | -2.148 | -2.143 | -2.016 | -1.43 | 0.407 | 0 | 0.529 |
| Net Income
| -17.862 | -14.052 | 3.063 | 1.756 | -2.086 | -3.492 | -3.254 | -2.671 | -3.027 | -2.659 | -1.728 | -2.014 |
| Net Income Ratio
| -1.829 | -0.83 | 0.086 | 0.062 | -0.185 | -0.497 | -0.652 | -0.658 | -0.927 | -2.549 | -1.337 | -7.839 |
| EPS
| -0.11 | -0.096 | 0.021 | 0.012 | -0.016 | -0.033 | -0.031 | -0.028 | -0.042 | -0.053 | -0.025 | -0.079 |
| EPS Diluted
| -0.11 | -0.096 | 0.021 | 0.012 | -0.016 | -0.033 | -0.031 | -0.028 | -0.042 | -0.053 | -0.025 | -0.079 |
| EBITDA
| -20.338 | -17.365 | 4.583 | 2.982 | -3.947 | -3.128 | -2.766 | -2.304 | -2.599 | -2.453 | -1.131 | -2.205 |
| EBITDA Ratio
| -2.083 | -1.025 | 0.129 | 0.105 | -0.35 | -0.445 | -0.554 | -0.567 | -0.796 | -2.351 | -0.875 | -8.581 |